Loading…
Tuesday, May 7 • 11:00am - 11:45am
Building Out Your Medical Affairs Team: How Early is Too Early?

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
  • Discuss advantages of integrating Medical Affairs functions at an earlier stage in the development timeline of assets, exploring the impact on the overall success of the company
  • Delve into the need for early collaboration to integrate evidence generation, patient considerations, and market readiness into launch planning
  • Advocate for a shift in mindset within R&D, emphasizing the importance of considering commercialization aspects throughout the clinical trial process
  • Identify effective coordination between R&D and medical affairs is essential for integrating evidence generation and patient considerations into launch planning, creating a seamless transition from clinical trials to commercialization
  • Explore how Medical Affairs functions in emerging biotech companies can adapt to and leverage evolving trends in precision medicine, real-world evidence, and patient-centric approaches
Moderators
avatar for Kanchan Relwani

Kanchan Relwani

Senior Vice President, Head of Medical Affairs, Alkermes
Kanchan Relwani, M.D. serves as Alkermes’ Senior Vice President of Medical Affairs. In this role, Dr. Relwani leads the Medical Affairs organization, including oversight of the Medical Strategy, Medical Operations & Alliances, Heath Economics and Outcomes Research, Medical Information... Read More →

Speakers
avatar for Tonia Nesheiwat, PharmD

Tonia Nesheiwat, PharmD

Vice President of Medical Affairs and Project Leadership, Caribou Biosciences
Tonia is the vice president of medical affairs and project leadership at Caribou Biosciences, responsible for developing and executing medical affairs strategy and supporting new product development. She brings 15 years of clinical development, submission and medical affairs experience... Read More →
avatar for Asya Kogan

Asya Kogan

Executive Director, Field Medical Oncology, Eisai
Asya Kogan, Pharm.D., serves as Executive Director, Field Medical, Global & US Oncology Medical Affairs at Eisai Inc. In this role, Dr. Kogan leads the Field Medical Affairs function in Oncology, including managing the Regional Directors of MSLs, Field Medical Directors and Field... Read More →
avatar for Sunil Mehta

Sunil Mehta

Vice President, Head of US Medical Affairs, Argenx
Sunil completed his PharmD from Rutgers University followed by a Medical Affairs and Medical Strategy post-doctoral fellowship at BMS in Cardiology & Infectious Diseases (ID) where he was involved in helping develop Medical strategy & Training for Medical Affairs and Commercial organizations... Read More →
avatar for Lorena Griparic, Ph.D.

Lorena Griparic, Ph.D.

Director, Medical Affairs and Safety, MannKind Corporation
Lorena is an experienced Medical Affairs professional, bringing to the discussion table > 15 years of biotech/pharmaceutical/device industry experience in various therapeutic areas, including diabetes, bone health, nephology, rare disease, ophthalmology. She is currently the Director... Read More →

Tuesday May 7, 2024 11:00am - 11:45am EDT
Newport III
  Track: Medical Affairs Strategy